Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

NDAQ:APHA - Post Discussion

Aphria Inc. > Canopy Growth’s CEO & Former Chairman Klein vs Simon
View:
Post by Savage97 on Sep 04, 2020 10:41am

Canopy Growth’s CEO & Former Chairman Klein vs Simon

CGC has managed to burn through $3 billion of cash while diluting shareholders by 20%.  CGC has seen weak gross margins: past quarter saw gross margins of 6%.  Selling, general, & administrative expenses totaled $135.4 million:  $16 million higher than total revenues. CGC has decided to go the direction of less-clarity, as in this most recent quarter it has decided to stop disclosing kilograms sold and average selling prices.

 

Aphria's 2020 fiscal year highlights:

Adjusted EBITDA grew from $209,000 to CA$8.6 million, with 52.9% gross margin in selling cannabis.  Revenue grew by 129% to CA$543.3 million, compared with CA$237.1 million in 2019. Aphria's cash cost decreased, sales were up 18.4% from the prior-year period.  Aphria is ranked No. 1 in the adult-use recreational market in Canada and the market leader for Vapes.  Aphria expanding into Germany with in country production facility and exports Europe from Aphria One.
Comment by Steve0123 on Sep 04, 2020 3:49pm
Not to mention probably the most layoffs to date.  https://www.ctvnews.ca/mobile/business/canopy-growth-lays-off-more-workers-won-t-say-how-many-impacted-by-cuts-1.5092822
Aphria Inc.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities